Continuous morphine infusion: A retrospective study of efficacy, safety, and demographic variables

Neuromodulation

Volumn 12, Issue 2, 2009, Pages 122-129

  Reig, Enrique ^b   Abejón, David ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b Madrid Pain Clinic   (Spain)

Author keywords

Cancer pain; Intrathecal infusion; Intrathecal morphine; Neuropathic pain; Nonmalignant chronic pain

Indexed keywords

MORPHINE;

ADOLESCENT; ADULT; AGED; AMNESIA; ANALGESIA; ANOREXIA; ARTICLE; ASTHENIA; CANCER PAIN; CHI SQUARE TEST; CONSTIPATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DEMOGRAPHY; DIAPHORESIS; DISORIENTATION; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; HUMAN; IMPOTENCE; LIBIDO DISORDER; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENINGISM; MENINGITIS; MENTAL CONCENTRATION; MULTIVARIATE ANALYSIS; MYOCLONUS; NAUSEA; NEUROPATHIC PAIN; PAIN; PAIN ASSESSMENT; PERSONALITY; POSTDURAL PUNCTURE HEADACHE; PRURITUS; RATING SCALE; RETROSPECTIVE STUDY; RISK; SIDE EFFECT; SOMNOLENCE; STATISTICAL ANALYSIS; THERAPY EFFECT; UNIVARIATE ANALYSIS; UNSTEADINESS; URINE RETENTION; VOMITING;

EID: 65349091940     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2009.00206.x     Document Type: Article

References (32)

1. La Motte C, Pert CB, Zinder SH. Opiate receptor binding in primate spinal cord: distribution and changes alter dorsal root section. Brain Res 1976 112 : 407 412.
2. Deer T, Winkermuller W, Erdine S, Bedder M, Burchiel K. Intrathecal therapy for cancer and nonmalignant pain, patients selection and patients management. Neruomodulation 1999 2 : 55 66.
3. Krames E, Lanning RM. Intrathecal infusional analgesia for nonmalignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine. J Pain Symptom Manage 1993 8 : 539 548.
4. Lamer TJ. Treatment of cancer related pain: when orally administered medication fail. Mayo Clin Proc 1994 69 : 473 480.
5. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic non-cancer pain: a retrospective multi-center study. J Pain Symptom Manage 1996 11 : 71 80.
6. Rainov NG, Heidecke V, Burkert W. Long-term intrathecal infusion of drug combinations for chronic back and leg pain. J Pain Symptom Manage 2001 22 : 862 871.
7. Coombs DW, Saunders RL, Taylor MS, Leite MG, Shaiberger C. Continuous epidural analgesia via implanted morphine reservoir. Lancet 1981 2 : 425 426.
8. Onofrio BM, Yansh TL, Arnold PG. Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 1981 56 : 516 520.
9. Bennett G, Serafini M, Burchiel K et al. Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manage 2000 20 : S12 S36.
10. Deer T, Krames ES, Hassenbusch S. Future directions for intrathecal pain management: a review and update from the Interdisciplinary Polyanalgesic Consensus Conference 2007. Neuromodulation 2008 11 : 92 97.
11. Anderson VA, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999 44 : 289 301.
12. Mironer YE, Haasis JC, Chapple I, Brown C, Satterthwaite JR. Efficacy and safety of intrathecal opioid/bupivacaine mixture in chronic nonmalignant pain: a double blind, randomized, crossover, multicenter study by the National Forum of Independent Pain Clinicians (NFIPC). Neuromodulation 2002 4 : 208 213.
13. Thimineura MA, Kravitzb E, Vodapally MS. Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study. Pain 2004 109 : 242 249.
14. Raffaeli W, Andruccioli J, Righetti D, Caminiti A, Balestri M. Intraspinal therapy for the treatment of chronic pain: a review of the literature between 1990 and 2005 and suggested protocol for its rational and safe use. Neuromodulation 2006 9 : 290 308.
15. Mercadante S. Problems of long-term spinal opioid treatment in advanced cancer patients. Pain 1999 79 : 1 13.
16. Naumann C, Erdine S, Koulonsakis A, Van Buyten JP, Schuchard M. Drug adverse event and system complication of intrathecal opioid delivery for pain: origins, detection, manifestation and management. Neuromodulation 1999 2 : 92 107.
17. Dominguez E, Sahinler B, Bassam D et al. Predictive value of intrathecal narcotic trials for long-term therapy with implantable drug administration systems in chronic non-cancer pain patients. Pain Pract 2002 2 : 315 325.
18. Penn Rd Paice JA. Chronic intrathecal morphine for intractable pain. J Neurosurg 1987 67 : 182 186.
19. Follet KA, Hitchon PW, Piper J, Kumar V, Clamon G, Jones MP. Response of intractable pain to continuous intrathecal morphine: a retrospective study. Pain 1992 49 : 21 25.
20. Chambers FA, McSullivan R. Intrathecal morphine in the treatment of chronic intractable pain. Ir J Med Sci 1994 163 : 318 321.
21. Smith TJ, Coyne PJ, Staats PS et al. An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM). Ann Oncol 2005 16 : 825 833.
22. Smith TJ, Staats P, Deer T et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002 20 : 4040 4049.
23. Muller-Schwefe G, Hassenbusch SJ, Reig E. Cost effectiveness of intrathecal therapy for pain. Neuromodulation 1999 2 : 77 84.
24. Tutak U, Doleys DM. Intrathecal infusion systems for treatment of chronic low back and leg pain of noncancer origin. South Med J 1996 89 : 295 300.
25. Deer T, Chapple I, Classen A, Javery K, Stoke V, Tonder L, Burchiel K. Intrathecal drug delivery for treatment of chronic low back pain: report from the national outcomes registry for low back pain. Pain Med 2004 5 : 6 13.
26. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996 85 : 458 467.
27. Winkelmuller M, Burchiel K, Van Buyten J. Intrathecal therapy for pain: efficacy and outcome. Neuromodulation 1999 2 : 67 76.
28. Paice JA, Windkelmuller W, Burchiel K, Racz GB, Prager JP. Clinical realities and economic consideration: efficacy of intrathecal pain therapy. J Pain Symptom Manage 1997 14 (Suppl 14 36.
29. Krames ES. Intraspinal opioids therapy for chronic nonmalignant pain: current practice and clinical guidelines. J Pain Symptom Manage 1996 11 : 333 352.
30. Naumann C, Erdine S, Koulousakis A, Van Buyten JP, Schuchard M. Drug adverse events and systemic complications of intrathecal opioid delivery for pain: origins, detection, manifestations, and management. Neuromodulation 1999 2 : 92 107.
31. Erdine S, Yucel A. Intrathecal morphine delivered by implanted manual pump for cancer pain. Pain Digest 1996 6 : 161 165.
32. Krames ES. The chronic intraspinal use of opioid and local anesthetic mixture for the relief of intractable pain. When all else fails! Pain 1993 55 : 1 4.